Feds Also Warn the Issue Could Affect the Dose of Insulin Delivered to a Patient
Federal authorities have issued urgent advisories – and Medtronic a voluntary product recall – about a cybersecurity flaw in some of the company’s insulin pumps. If exploited, the flaw could result in patients receiving too little or too much insulin, which in extreme cases could result in death.Leer másDataBreachToday.com RSS Syndication
Views: 0
